Cutaneous Myelofibrosis With JAK2 V617F Mutation: Metastasis, Not Merely Extramedullary Hematopoiesis!

被引：11

作者：

Fraga, Garth R. ^{[1
]}

Caughron, Samuel K. ^{[2
]}

机构：

[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA

[2] MAWD Pathol Grp, Kansas City, MO USA

来源：

AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2010年 / 32卷 / 07期

关键词：

myelofibrosis; extramedullary hematopoiesis; metastasis; JAK2; leukemia; MYELOID METAPLASIA; IDIOPATHIC MYELOFIBROSIS; SKIN; MANIFESTATION; PATHOGENESIS;

D O I：

10.1097/DAD.0b013e3181d3ca2f

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm. There are 31 reported cases of cutaneous involvement by PMF, most of which have been described as "extramedullary hematopoiesis.'' We report a new case of cutaneous involvement by PMF and demonstrate mutation of the Janus kinase 2 gene in the cutaneous lesions. Extramedullary myelofibrosis is best considered a metastatic phenomenon. Reporting such cases as extramedullary hematopoiesis may cause confusion with reactive forms of extramedullary hematopoiesis.

引用

页码：727 / 730

页数：4

共 50 条

[31] Absence of JAK2 V617F mutation in gastric cancers
Lee, JW
Soung, YH
Kim, SY
Nam, SW
Park, WS
Lee, JY
Yoo, NJ
Lee, SH
ACTA ONCOLOGICA, 2006, 45 (02) : 222 - 223
[32] Immature Platelet Fraction Is Associated with JAK2 V617F Mutation and Features of Advanced Disease in Myelofibrosis
Strati, Paolo
Bose, Pritviraj
Gaw, Katie
Zhou, Lingsha
Pierce, Sherry
Huynh-Lu, Julie
Bueso-Ramos, Carlos E.
Verstovsek, Srdan
BLOOD, 2016, 128 (22)
[33] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
Fiorini, A.
Reddiconto, G.
Farina, G.
Marietti, S.
Palladino, M.
Chiusolo, P.
Leone, G.
Sica, S.
LEUKEMIA, 2006, 20 (12) : 2198 - 2199
[34] Myelodysplastic syndromes with myelofibrosis may be a target for the JAK2 V617F tyrosine kinase mutation.
Ohyashiki, K
Aota, Y
Gotoh, A
Miyazawa, K
Kimura, Y
Ohyashiki, JH
BLOOD, 2005, 106 (11) : 304B - 304B
[35] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
Fiorini, A.
Reddiconto, G.
Farina, G.
Marietti, S.
Palladino, M.
Giammarco, S.
Chiusolo, P.
Leone, G.
Sica, S.
BONE MARROW TRANSPLANTATION, 2007, 39 : S298 - S298
[36] Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia
A Fiorini
G Reddiconto
G Farina
S Marietti
M Palladino
P Chiusolo
G Leone
S Sica
Leukemia, 2006, 20 : 2198 - 2199
[37] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
Hamidah, N.
Farisah, N.
Jalil, N.
Fei-Liang, W.
AWahid, F.
Othman, A.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
[38] JAK2 V617F MUTATION SCANNING IN PATIENTS WITH ADRENAL INCIDENTALOMA
Ekinci, F.
Soyaltin, U. E.
Kutbay, Y. B.
Yasar, H. Y.
Yildirim, T. Demirci
Akar, H.
ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (02) : 150 - 153
[39] JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia
Johan, MF
Goodeve, AC
Bowen, DT
Frew, ME
Reilly, JT
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (06) : 968 - 968
[40] THE JAK2 V617F MUTATION IN RETINAL VEIN OR ARTERY OCCLUSION
Langabeer, Stephen E.
EXCLI JOURNAL, 2019, 18 : 127 - 128

← 1 2 3 4 5 →